Further research, including larger validation cohorts and prospective data about clinical outcomes, is needed to clarify the role of FGF-23 as a marker and potentially also a mediator and novel therapeutic target in carotid atherosclerosis. Here, FGF23 is linked to carotid atherosclerosis.